ALS Posts Record FY26; Q1 FY27 Growth On Track

In an address to the 2026 Annual General Meeting, ALS Limited (ASX:ALQ)'s CEO and Managing Director reviewed FY26 performance and provided a first-quarter FY27 trading update. In FY26, the Minerals business delivered 20.2% organic growth and a record year of samples processed, with margin expanding to 33%. Within Industrial Materials, Oil & Lubricants grew 12.2% organically and Assay & Inspection 11.4%, while Coal grew 7.6%. The Environmental business, the Group's largest at 35% of revenue, delivered mid-single digit organic growth, Food grew 7.2%, and Pharma recorded a slight organic revenue decline of 1.6%, though Nuvisan EBIT grew 123% with margin improvement of approximately 450 basis points.

For Q1 FY27, ALS said it remains on track to deliver high single-digit organic revenue growth and margin improvement consistent with FY26. Commodities organic revenue growth is trending above the 15-17% guided H1 range, with Minerals running ahead of expectations, while Oil & Lubricants was slightly behind. Life Sciences delivered low single-digit organic growth, with Food mid-single digit, Environmental low single-digit and Pharma negative low single-digit. The Company also confirmed it has signed an agreement to acquire an additional 18% interest in its existing Saudi joint venture, increasing its total holding to 60%, pending regulatory approvals, with completion anticipated in the coming weeks.